v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2026
Jul. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 30,497 $ 52,769
Prepaid clinical costs 2,919 1,045
Other receivables 1,206
Accounts receivable, net of allowance for credit losses of $245 at April 30, 2026 and July 31, 2025 294 627
Inventory 276 281
Prepaid expenses and other current assets 872 786
Total current assets 34,858 56,714
Property and equipment, net 1,524 1,596
Non-current prepaid clinical costs 244 1,399
Convertible notes receivable classified as available-for-sale 2,124 1,858
Goodwill 19,939 19,939
Intangible assets, net 896 994
In-process research and development 31,575 31,575
Investments 750
Other assets 80 34
TOTAL ASSETS 91,990 114,109
CURRENT LIABILITIES    
Accounts payable 7,043 6,893
Accrued expenses 2,764 3,304
Convertible notes payable 608 614
Other current liabilities 70 66
Total current liabilities 11,020 11,600
Accrued expenses, noncurrent 3,895
Convertible notes payable, noncurrent 2 78
Deferred income tax liability 138 138
Other liabilities 27 27
TOTAL LIABILITIES 11,187 15,738
COMMITMENTS AND CONTINGENCIES
EQUITY    
Additional paid-in capital 323,234 322,161
Accumulated deficit (252,722) (232,263)
Accumulated other comprehensive income related to unrealized income on available-for-sale securities 624 358
Accumulated other comprehensive income related to foreign currency translation adjustment 3,897 3,787
Total equity attributable to Rafael Holdings, Inc. 75,386 94,391
Noncontrolling interests 5,417 3,980
TOTAL EQUITY 80,803 98,371
TOTAL LIABILITIES AND EQUITY 91,990 114,109
Related Parties    
CURRENT LIABILITIES    
Due to related parties, net 535 723
Class A Common Stock    
EQUITY    
Common stock value 8 8
Class B Common Stock    
EQUITY    
Common stock value 513 508
Class B Treasury Stock    
EQUITY    
Treasury stock, at cost; 101,487 Class B shares as of April 30, 2026 and July 31, 2025 $ (168) $ (168)